BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis

PLoS One. 2013 Dec 20;8(12):e83250. doi: 10.1371/journal.pone.0083250. eCollection 2013.

Abstract

Gliomas are common and lethal tumors of the central nervous system (CNS). Genetic alterations, inflammatory and angiogenic processes have been identified throughout tumor progression; however, treatment still remains palliative for most cases. Biological research on parameters influencing cell survival, invasion and tumor heterogeneity identified several cytokines interfering in CNS inflammation, oxidative stress and malignant transformation, including TNF-superfamily (TNFSF) members. In this report we performed a meta-analysis of public gene-array data on the expression of a group of TNFSF ligands (BAFF, APRIL, TWEAK) and their receptors (BAFF-R, TACI, BCMA, Fn14) in gliomas. In addition, we investigated by immunohistochemistry (IHC) the tumor cells' expression of these ligands and receptors in a series of 56 gliomas of different grade. We show that in IHC, BAFF and APRIL as well as their cognate receptors (BCMA, TACI) and Fn14 expression correlate with tumor grade. This result was not evidenced in micro-arrays meta-analysis. Finally, we detected for the first time Fn14, BAFF, BCMA and TACI in glioma-related vascular endothelium. Our data, combined with our previous report in glioma cell lines, suggest a role for these receptors and ligands in glioma biology and advance these molecules as potential markers for the classification of these tumors to the proliferative, angiogenic or stem-like molecular subtype.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Cell Activating Factor / genetics*
  • B-Cell Activating Factor / metabolism
  • B-Cell Maturation Antigen / genetics*
  • B-Cell Maturation Antigen / metabolism
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Central Nervous System Neoplasms / genetics*
  • Central Nervous System Neoplasms / metabolism
  • Central Nervous System Neoplasms / pathology
  • Cytokine TWEAK
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Gene Expression Regulation, Neoplastic
  • Glioma / genetics*
  • Glioma / metabolism
  • Glioma / pathology
  • Humans
  • Immunohistochemistry
  • Microarray Analysis
  • Neoplasm Grading
  • Receptors, Tumor Necrosis Factor / genetics*
  • Receptors, Tumor Necrosis Factor / metabolism
  • TWEAK Receptor
  • Transmembrane Activator and CAML Interactor Protein / genetics*
  • Transmembrane Activator and CAML Interactor Protein / metabolism
  • Tumor Necrosis Factor Ligand Superfamily Member 13 / genetics*
  • Tumor Necrosis Factor Ligand Superfamily Member 13 / metabolism
  • Tumor Necrosis Factors / genetics*
  • Tumor Necrosis Factors / metabolism

Substances

  • B-Cell Activating Factor
  • B-Cell Maturation Antigen
  • Biomarkers, Tumor
  • Cytokine TWEAK
  • Receptors, Tumor Necrosis Factor
  • TNFRSF12A protein, human
  • TNFRSF13B protein, human
  • TNFRSF17 protein, human
  • TNFSF12 protein, human
  • TNFSF13B protein, human
  • TWEAK Receptor
  • Transmembrane Activator and CAML Interactor Protein
  • Tumor Necrosis Factor Ligand Superfamily Member 13
  • Tumor Necrosis Factors

Grants and funding

This work was partially supported by the European Union-FP7 Marie Curie Actions-Career Reintegration Grants PCIG-GA-2011-303723 (to VP) and the University of Crete Research Committee funds to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.